Radiation-Induced Optic Neuropathy: Literature Review

References

• Dhermain F, Barani IJ. Complications from radiotherapy. Handb Clin Neurol. 2016;134:219–234.
   PubMedGoogle Scholar
• Kanda T, Wakabayashi Y, Zeng F, et al. Imaging findings in radiation therapy complications of the central nervous system. Jpn J Radiol. 2018;36(9):519–527. doi:10.1007/s11604-018-0759-7.
   PubMed Web of Science ®Google Scholar
• Spiotto MT, Connell PP. Strategies to Overcome Late Complications from Radiotherapy for Childhood Head and Neck Cancers. Oral Maxillofac Surg Clin North Am. 2016;28(1):115–126. doi:10.1016/j.coms.2015.07.009.
   PubMed Web of Science ®Google Scholar
• Moding EJ, Kastan MB, Kirsch DG. A fuzzy approach and modelling of service estimations for drugs freight transportation. Transp Telecommun. 2010; 11(1):19–25.
   Google Scholar
• Mohamed Ali A, Mathis T, Bensadoun R-J, Thariat J. Radiation induced optic neuropathy: does treatment modality influence the risk? Bull Cancer. 2019;106(12):1160–1176. Internet]. Available from. 10.1016/j.bulcan.2019.09.008.
   PubMed Web of Science ®Google Scholar
• Loganovsky KN, Marazziti D, Fedirko PA, et al. Radiation-Induced Cerebro-Ophthalmic Effects in Humans. Life. 2020;10(4):1–17. doi:10.3390/life10040041.
   Google Scholar
• Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15(2):95–100. doi:10.1016/j.jocn.2007.09.004.
   PubMed Web of Science ®Google Scholar
• Kline LB, Kim JY, Ceballos R. Radiation Optic Neuropathy. Ophthalmology. 1985;92(8):1118–1126. doi:10.1016/S0161-6420(85)33898-8.
   PubMed Web of Science ®Google Scholar
• Borruat FX, Schatz NJ, Glaser JS, Matos L, Feuer W. Radiation optic neuropathy: report of cases, role Of hyperbaric oxygen therapy, and literature review. Neuro-Ophthalmology. 1996;16:255–266.
   Web of Science ®Google Scholar
• Biousse V. Chapter. 5 Ischemic Optic Neuropathies. Blue Books Neurol. 2008; 32:112–133. doi:10.1016/S1877-184X(09)70035-8
   Google Scholar
• Lessell S. Friendly fire: neurogenic visual loss from radiation therapy. J Neuroophthalmol. 2004;24(3):243–250. doi:10.1097/00041327-200409000-00014.
   PubMed Web of Science ®Google Scholar
• Speckter H, Bido J, Hernandez G, Rivera D, Suazo L, Valenzuela S, Fermin , Oviedo J, Foerster B, Gonzalez C, Stoeter P. Inversion recovery sequences improve delineation of optic pathways in the proximity of suprasellar lesions. J Radiosurgery SBRT. 2018;5(2):115–122.
   PubMed Web of Science ®Google Scholar
• Archer EL, Liao EA, Trobe JD. Radiation-induced optic neuropathy: clinical and imaging profile of twelve patients. J Neuroophthalmol. 2019;39(2):170–180. doi:10.1097/WNO.0000000000000670.
   PubMed Web of Science ®Google Scholar
• Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res. 2012;177(3):229–243. doi:10.1667/RR2629.1.
   PubMed Web of Science ®Google Scholar
• United Nations Scientific Committee on the Effects of Atomic Radiation. Report to the General Assembly Scientific Volume 1 Annexes A and B. United Nations. 2014. 1–311 p.
   Google Scholar
• Khong PL, Ringertz H, Donoghue V, Frush D, Rehani M, Applegate K, Sanchez R. Preface. Ann ICRP. 2013;42(2):11.
   Google Scholar
• Brenner DJ, Elliston CD, Hall EJ, Berdon WE. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol. 2004;24(2):(February):289–96. doi:10.2214/ajr.176.2.1760289.
   Web of Science ®Google Scholar
• Pearce MS, Salotti JA, Howe NL, McHugh K, Kim KP, Lee C, Craft AW, Berrington de Gonzalez A, Parker L. CT scans in young people in great britain: temporal and descriptive patterns, 1993–2002. Radiol Res Pract. 2012;2012:1–8. doi:10.1155/2012/594278.
   Google Scholar
• McHugh K, Disini DL. Commentary: for the children’s sake, avoid non-contrast CT. Cancer Imaging. 2011;11(1):16–18. doi:10.1102/1470-7330.2011.0003.
   PubMed Web of Science ®Google Scholar
• Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994;30(4):755–763. doi:10.1016/0360-3016(94)90346-8.
   PubMed Web of Science ®Google Scholar
• Forrest APM, Brown DAP, Morris SR, et al. Pituitary Radon Implant for Advanced Cancer. Lancet. 1956;267(6920):399–401. doi:10.1016/S0140-6736(56)90470-6.
   Google Scholar
• Buys NS, Kerns TC. Irradiation damage to the chiasm. Am J Ophthalmol. 1957;44(4PART 1):483–486. Internet]. ;(): . Available from. 10.1016/0002-9394(57)90147-2. .
   PubMed Web of Science ®Google Scholar
• Ferguson I, Huecker J, Huang J, McClelland C, Van Stavern G. Risk factors for radiation-induced optic neuropathy: a case–control study. Clin Exp Ophthalmol. 2017;45(6):592–597. doi:10.1111/ceo.12927.
   PubMed Web of Science ®Google Scholar
• Wang W, Yang H, Guo L, et al. Radiation-induced optic neuropathy following external beam radiation therapy for nasopharyngeal carcinoma: a retrospective case-control study. Mol Clin Oncol. 2016;4(5):868–872. doi:10.3892/mco.2016.787.
   PubMed Web of Science ®Google Scholar
• Seregard S, Pelayes DE, Singh AD. Radiation therapy: posterior segment complications. Dev Ophthalmol. 2013;52:114–123.
   PubMedGoogle Scholar
• Ballian N, Androulakis II, Chatzistefanou K, Samara C, Tsiveriotis K, Kaltsas GA. Optic neuropathy following radiotherapy for Cushing’s disease: case report and literature review. Hormones. 2010;9(3):269–273. doi:10.1007/BF03401278.
   PubMedGoogle Scholar
• Pollock BE, Link MJ, Leavitt JA, Stafford SL. Dose-volume analysis of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Neurosurgery. 2014;75(4):456–460. doi:10.1227/NEU.0000000000000457.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109–122. doi:10.1016/0360-3016(91)90171-Y.
   PubMed Web of Science ®Google Scholar
• Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976;120(1):167–171. doi:10.1148/120.1.167.
   PubMed Web of Science ®Google Scholar
• Deng X, Yang Z, Liu R, et al. The maximum tolerated dose of gamma radiation to the optic nerve during gamma knife radiosurgery in an animal study. Stereotact Funct Neurosurg. 2013;91(2):79–91. doi:10.1159/000343212.
   PubMed Web of Science ®Google Scholar
• Jiangt GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 1994;30(1):17–25. doi:10.1016/0167-8140(94)90005-1.
   PubMed Web of Science ®Google Scholar
• Stafford SL, Pollock BE, Leavitt JA, et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2003;55(5):1177–1181. doi:10.1016/S0360-3016(02)04380-8.
   PubMed Web of Science ®Google Scholar
• Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation Dose–Volume Effects of Optic Nerves and Chiasm. Int J Radiat Oncol Biol Phys. 2010;76(3):28–35. doi:10.1016/j.ijrobp.2009.07.1753.
   Web of Science ®Google Scholar
• Somani S, Sahgal A, Krema H, et al. Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: 2-Year follow-up. Can J Ophthalmol. 2009;44(1):61–65. Available from. doi:10.3129/i08-177.
   PubMed Web of Science ®Google Scholar
• Kim JO, Ma R, Akagami R, et al. Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC cancer agency. Int J Radiat Oncol Biol Phys. 2013;87(3):528–533. doi:10.1016/j.ijrobp.2013.06.2057.
   PubMed Web of Science ®Google Scholar
• Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005;62(4):1070–1077. doi:10.1016/j.ijrobp.2004.12.009.
   PubMed Web of Science ®Google Scholar
• Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology. 1997;104(10):1634–1643. doi:10.1016/S0161-6420(97)30084-0.
   PubMed Web of Science ®Google Scholar
• Guy J, Mancuso A, Beck R, et al. Radiation-induced optic neuropathy: A magnetic resonance imaging study. J Neurosurg. 1991;74(3):426–432. doi:10.3171/jns.1991.74.3.0426.
   PubMed Web of Science ®Google Scholar
• Schreiber S, Prox-Vagedes V, Elolf E, et al. Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: A case report. BMC Cancer. 2010;10(1):0–4. doi:10.1186/1471-2407-10-520.
   Web of Science ®Google Scholar
• Griffin JD, Garnick M. Eye toxicity of cancer chemotherapy: a review of the literature. Cancer. 1981;48:1539–1549.
   PubMed Web of Science ®Google Scholar
• Sanderson PA, Kuwabara T, Cogan DG. Optic neuropathy presumably caused by vincristine therapy. Am J Ophthalmol. 1976;81(2):146–150. doi:10.1016/0002-9394(76)90725-X. .
   PubMed Web of Science ®Google Scholar
• Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999;106(8):1571–1578. doi:10.1016/S0161-6420(99)90455-4.
   PubMed Web of Science ®Google Scholar
• Azzam EI, De Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci USA. 2001;98(2):473–478. doi:10.1073/pnas.011417098.
   PubMed Web of Science ®Google Scholar
• Viana PHL, Góes AM, Gomes DA, Grynberg SE. Verificação experimental para confirmação de técnica in vitro do efeito bystander induzido por radiação gama na linhagem celular CHO-K1. Sci Plena. 2013;9:1–9.
   Google Scholar
• Schettino G, Folkard M, Prise KM, Vojnovic B, Held KD, Michael BD. Low-Dose Studies of Bystander Cell Killing with Targeted Soft X Rays. Radiat Res. 2003;160(5):505–511. doi:10.1667/RR3060.
   PubMed Web of Science ®Google Scholar
• Shao C, Stewart V, Folkard M, Michael BD, Prise KM. Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Res. 2003;63:8437–8442.
   PubMed Web of Science ®Google Scholar
• Van Der Kogel AJ. Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer. 1986;53:207–217.
   Web of Science ®Google Scholar
• Hopewell JW. Van Der Kogel AJ. Pathophysiological mechanisms leading to the development of late radiation-induced damage to the central nervous system. Front Radiat Ther Oncol. 1999;33:265–275.
   PubMedGoogle Scholar
• Myers R, Rogers MA, Hornsey S. A reappraisal of the roles of glial and vascular elements in the development of white matter necrosis in irradiated rat spinal cord. Br J Cancer. 1986;53:221–223.
   Web of Science ®Google Scholar
• Omary RA, Berr SS, Kamiryo T, et al. Gamma knife irradition—Induced changes in the normal rat brain studied with 1H magnetic resonance spectroscopy and imaging. Acad Radiol. 1995;2(12):1043–1051. doi:10.1016/S1076-6332(05)80511-2.
   PubMed Web of Science ®Google Scholar
• Levin LA, Gragoudas ES, Lessell S. Endothelial cell loss in irradiated optic nerves. Ophthalmology. 2000;107(2):370–374. doi:10.1016/S0161-6420(99)00054-8.
   PubMed Web of Science ®Google Scholar
• Miller NR. Radiation-induced optic neuropathy: still no treatment. Clin Exp Ophthalmol. 2004;32(3):233–235. doi:10.1111/j.1442-9071.2004.00809.x.
   PubMed Web of Science ®Google Scholar
• Crompton MR, Layton DD. Delayed radionecrosis of the brain following therapeutic X-radiation of the pituitary. Brain. 1961;84(1):85–101. doi:10.1093/brain/84.1.85.
   PubMed Web of Science ®Google Scholar
• Ross HS, Rosenberg S, Friedman AH. Delayed radiation necrosis of the optic nerve. Am J Ophthalmol. 1973;76(5):683–686. doi:10.1016/0002-9394(73)90563-1.
   PubMed Web of Science ®Google Scholar
• Brown GC, Shields JA, Sanborn G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation Retinopathy. Ophthalmology. 1982;89(12):1494–1501. Internet]. Available from. . doi:10.1016/S0161-6420(82)34611-4.
   PubMed Web of Science ®Google Scholar
• Archer DB, Amoaku WM, Gardiner TA. Radiation retinopathy—Clinical, histopathological, ultrastructural and experimental correlations. Eye (Lond). 1991;5(2):239–251. doi:10.1038/eye.1991.39.
   PubMedGoogle Scholar
• Van Den Bergh ACM, Schoorl MA, Dullaart RPF, et al. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol. 2004;24(3):200–205. doi:10.1097/00041327-200409000-00003.
   PubMed Web of Science ®Google Scholar
• Goldsmith BJ, Rosenthal SA, Wara WM, Larson DA. Optic neuropathy after irradiation of meningioma. Radiology. 1992;185(1):71–76. doi:10.1148/radiology.185.1.1523337.
   PubMed Web of Science ®Google Scholar
• Zimmerman CF, Schatz NJ, Glaser JS. Magnetic resonance imaging of radiation optic neuropathy. Am J Ophthalmol. 1990;110(4):389–394. doi:10.1016/S0002-9394(14)77019-9.
   PubMed Web of Science ®Google Scholar
• Young WC, Thornton AF, Gebarski SS, Cornblath WT. Radiation-induced optic neuropathy: correlation of MR imaging and radiation dosimetry. Radiology. 1992;185(3):904–907. doi:10.1148/radiology.185.3.1438784.
   PubMed Web of Science ®Google Scholar
• McClellan RL, Gammal TE, Kline LB. Early bilateral radiation-induced optic neuropathy with follow-up MRI. Neuroradiology. 1995;37(2):131–133. doi:10.1007/BF00588629.
   PubMed Web of Science ®Google Scholar
• Piquemal R, Cottier JP, Arsène S, et al. Radiation-induced optic neuropathy 4 years after radiation: report of a case followed up with MRI. Neuroradiology. 1998;40(7):439–441. doi:10.1007/s002340050619.
   PubMed Web of Science ®Google Scholar
• Garrott H, O’Day J. Optic neuropathy secondary to radiotherapy for nasal melanoma. Letters to the Editor. Clin Exp Ophthalmol. 2004;32(3):330–333. doi:10.1111/j.1442-9071.2004.00824.x.
   PubMed Web of Science ®Google Scholar
• Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm: clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology. 1990;97(3):346–351. doi:10.1016/S0161-6420(90)32582-4.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Lan Y, Bai S, et al. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma. J Clin Neurosci. 2013;20(5):702–706. doi:10.1016/j.jocn.2012.05.034.
   PubMed Web of Science ®Google Scholar
• Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013;27(2):163–171. doi:10.1038/eye.2012.249.
   PubMed Web of Science ®Google Scholar
• Weintraub JA, Bennett J, Gaspar LE. Successful treatment of radiation-induced optic neuropathy. Pract Radiat Oncol. 2011;1(1):40–44. doi:10.1016/j.prro.2010.09.004.
   PubMedGoogle Scholar
• Finger PT. Anti-VEGF bevacizumab (avastin®) for radiation optic neuropathy. Am J Ophthalmol. 2007;143(2):335–338. doi:10.1016/j.ajo.2006.09.014.
   PubMed Web of Science ®Google Scholar
• Indaram M, Ali FS, Levin MH. In search of a treatment for radiation-induced optic neuropathy. Curr Treat Options Neurol. 2015;17(1):1–9. doi:10.1007/s11940-014-0325-2.
   Web of Science ®Google Scholar
• Genc M, Genc E, Genc BO, Kiresi DA. Significant response of radiation induced CNS toxicity to high dose steroid administration. Br J Radiol. 2006;79(948):e196–e199. doi:10.1259/bjr/50789043.
   PubMedGoogle Scholar
• Barbosa AP, Carvalho D, Marques L, et al. Inefficiency of the anticoagulant therapy in the regression of the radiation-induced optic neuropathy in Cushing’s disease. J Endocrinol Invest. 1999;22(4):301–305. doi:10.1007/BF03343560.
   PubMed Web of Science ®Google Scholar
• Kim JH, Brown SL, Kolozsvary A, et al. Modification of Radiation Injury by Ramipril, Inhibitor of Angiotensin-Converting Enzyme, on Optic Neuropathy in the Rat. Radiat Res. 2004;32(3):330–333. doi:10.1667/RR3124.
   Web of Science ®Google Scholar
• Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neurooncol. 2007;82(2):119–124. doi:10.1007/s11060-006-9256-4.
   PubMed Web of Science ®Google Scholar
• Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology. 1986;93(8):1083–1088. doi:10.1016/S0161-6420(86)33617-0.
   PubMed Web of Science ®Google Scholar
• Levy RL, Miller NR. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore. 2006;35:151–157.
   PubMed Web of Science ®Google Scholar
• Lee MS, Borruat FX. Should patients with radiation-induced optic neuropathy receive any treatment? J Neuroophthalmol. 2011;31(1):83–88. doi:10.1097/WNO.0b013e31820d5361.
   PubMed Web of Science ®Google Scholar
• Levin VA, Bidaut L, Hou P, et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys. 2011;79(5):1487–1495. doi:10.1016/j.ijrobp.2009.12.061.
   PubMed Web of Science ®Google Scholar
• Farooq O, Lincoff NS, Saikali N, Prasad D, Miletich RS, Mechtler LL. Novel treatment for radiation optic neuropathy with intravenous bevacizumab. J Neuroophthalmol. 2012;32(4):321–324. doi:10.1097/WNO.0b013e3182607381.
   PubMed Web of Science ®Google Scholar
• Finger PT, Chin KJ. Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(2):789–798. doi:10.1016/j.ijrobp.2010.11.075.
   PubMed Web of Science ®Google Scholar
• Ranpura V, Hapani S, Wu S. Treatment-Related Mortality With Bevacizumab in Cancer Patients. J Am Med Assoc. 2011;305(5):487–494. doi:10.1001/jama.2011.51.
   PubMed Web of Science ®Google Scholar
• Bukowski RM. Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab. Cancer Manag Res. 2010;2(1):83–96. doi:10.2147/CMAR.S7540.
   PubMedGoogle Scholar
• Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22(11):2184–2191. doi:10.1200/JCO.2004.11.022.
   PubMed Web of Science ®Google Scholar